FDA Inspection 1004237 — Sterling Pharma Ringaskiddy Limited

Sterling Pharma Ringaskiddy Limited — FEI 3002807776

The FDA completed an inspection of Sterling Pharma Ringaskiddy Limited on February 3, 2017 in Ringaskiddy. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 3, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ringaskiddy (Ireland)